Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
3.260
+0.220 (7.24%)
At close: May 28, 2025, 4:00 PM
3.250
-0.010 (-0.31%)
After-hours: May 28, 2025, 5:39 PM EDT
Solid Biosciences Employees
Solid Biosciences had 100 employees as of December 31, 2024. The number of employees increased by 12 or 13.64% compared to the previous year.
Employees
100
Change (1Y)
12
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,396,760
Market Cap
252.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SLDB News
- 10 hours ago - Solid Biosciences to Participate at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 13 days ago - Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 27 days ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Solid Biosciences to Participate at The Citizens Life Sciences Conference - GlobeNewsWire
- 4 weeks ago - Solid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual Meeting - GlobeNewsWire
- 7 weeks ago - Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space - Seeking Alpha
- 2 months ago - Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul - New York Post
- 2 months ago - Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewsWire